Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-05T08:26:09.293Z Has data issue: false hasContentIssue false

Lamotrigine-Associated Depersonalization Symptoms

Published online by Cambridge University Press:  07 November 2014

Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters
Copyright
Copyright © Cambridge University Press 2010

References

2.Wang, SJ, Sihra, TS, Gea, PW. Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity. Neuropharmacol Neurotoxicol. 2001; 12(10): 22552258.Google ScholarPubMed
3.Anand, A, Charney, DS, Oren, D, et al. Attenuation of neuropsychiatric effects of ketamine with lamotrigine. Arch Gen Psychiatry. 2000; 57: 270276.CrossRefGoogle ScholarPubMed
4.Sierra, M, Phillips, M, Ivin, G, et al. A placebo-controlled, cross-over trial of Lamotrigine in depersonalization disorder. J Psychopharmacol. 2003; 17(1): 103105.CrossRefGoogle ScholarPubMed
5.Medford, N, Sierra, M, Baker, D, David, A. Understanding and treating depersonalization disorder. Advances in Psychiatric Treatment. 2005; 11: 92100.CrossRefGoogle Scholar
6.Sarkar, J, Jones, N, Sullivan, G. A case of depersonalization-derealization syndrome during treatment with Quetiapine. J Psychopharmacol. 2001; 15(3): 209211.CrossRefGoogle ScholarPubMed
7.Naranjo, CA, Busto, U, Sellers, EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30: 239245.CrossRefGoogle ScholarPubMed